Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05886998
Other study ID # FMASU MD 238/2020
Secondary ID
Status Completed
Phase Phase 3
First received
Last updated
Start date November 1, 2021
Est. completion date September 30, 2023

Study information

Verified date June 2024
Source Ain Shams University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to examine the value of nebulized heparin for prevention of acute lung injury in adult patients suffering smoke inhalation injury. Patients will be randomized to receive nebulized heparin or an equal volume of normal saline for 14 days and the incidence of acute lung injury will be compared in either group.


Description:

Adult patients who suffered smoke inhalation injury and who are candidates for elective intubation, have evidence of bronchial burn by fiberoptic bronchoscopy, have no evidence of acute lung injury and no more than 24 hours since inhalation injury will be included. Patients will be randomized into 2 groups: Group A (Intervention): Patients will receive 5000 IU heparin mixed with 3 ml saline and nebulized every 4 hours until they are extubated or until 14 days have elapsed whichever is earlier. Group B (Control): Patients will receive 4 ml of normal saline nebulized every 4 hours until they are extubated or until 14 days have elapsed whichever is earlier. Occurrence of acute lung injury will be assessed everyday for a maximum of 28 days. The primary end point is the occurrence of acute lung injury defined as defined by the Murray Lung Injury Score.


Recruitment information / eligibility

Status Completed
Enrollment 88
Est. completion date September 30, 2023
Est. primary completion date September 30, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Adult patients indicated for elective intubation: - History of being trapped in a house or industrial fire. - Production of carbonaceous sputum. - Perioral facial burns affecting nose, lips, mouth, or throat . - Altered level of consciousness at any time after the incident and including confusion. - Symptoms of respiratory distress including a sense of suffocation, choking, breathlessness, and wheezing or discomfort affecting the eyes or throat, including irritation of the mucosal membranes. - Signs of respiratory distress including stertorous or labored breathing, and tachypnea or auscultatory abnormalities, including crepitations or rhonchi. - Hoarseness or loss of voice. 2. Evidence of bronchial burn by bronchoscopy to assess severity of inhalational trauma - NO injury: absence of carbonaceous deposits, erythema, oedema, brochorrhea, or obstruction. - Mild injury: minor patchy areas of erythema or carbonaceous deposits in proximal or distal bronchi. - Moderate injury: moderate degree of erythema, carbonaceous deposits, bronchorrhea, or bronchial obstructions. - Sever injury: sever inflammation with friability, copious carbonaceous deposits, bronchorrhea, or obstruction. - Massive injury: evidence of mucosal sloughing, necrosis or endoluminal obliteration. 3. No evidence of acute lung injury at presentation (either by radiology or ABG) - Radiological findings: Normal lung without increased interstitial markings, ground glass opacification, or consolidation. - ABG findings : PaO2/ Fio2 > 300. 4. Time between inhalational injury and intubation not longer than 24 hours. Exclusion Criteria: 1. Burn injury > 24 hours. 2. History of pulmonary diseases. 3. Pregnancy or breast feeding. 4. History of allergy to heparin or HIT. 5. History or laboratory evidence of coagulopathy. 6. Burns area > 50% of total body surface area. -

Study Design


Intervention

Drug:
Heparin
Heparin sodium (Generic, 5000 IU/ml ampoules)
Other:
Normal Saline
0.9% sodium chloride solution (normal saline)

Locations

Country Name City State
Egypt Ain Shams University Hospitals Cairo

Sponsors (1)

Lead Sponsor Collaborator
Ain Shams University

Country where clinical trial is conducted

Egypt, 

References & Publications (1)

Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis. 1988 Sep;138(3):720-3. doi: 10.1164/ajrccm/138.3.720. No abstract available. Erratum In: Am Rev Respir Dis 1989 Apr;139(4):1065. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Occurrence of acute lung injury Acute lung injury is defined according to the Murray Lung Injury Score which comprises 4 items: chest radiograph, PaO2/FiO2, level of PEEP and pulmonary compliance.
Each of the 4 items is assigned a score from 0 to 4. The scores are then summed up and the total score is divided by the number of scored items and is interpreted as follows:
0 = no lung injury.
0.1-2.5 = mild to moderate lung injury.
>2.5 = severe lung injury. (Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis. 1988 Sep;138(3):720-3. doi: 10.1164/ajrccm/138.3.720. Erratum in: Am Rev Respir Dis 1989 Apr;139(4):1065. PMID: 3202424.)
28 days
Primary Occurrence of severe acute lung injury Murray Lung Injury Score >2.5 28 days
Secondary Duration of mechanical ventilation Time from institution to termination of mechanical ventilation 28 days
Secondary Mortality Survival to ICU discharge 28 days
Secondary Side effects Occurrence of heparin-induced adverse effects, e.g., thrombocytopenia, abnormal bleeding 28 days
See also
  Status Clinical Trial Phase
Recruiting NCT03937947 - Traumatic Brain Injury Associated Radiological DVT Incidence and Significance Study
Completed NCT04247477 - Comparison of Different PEEP Titration Strategies Using Electrical Impedance Tomography in Patients With ARDS N/A
Completed NCT03315702 - Effect of Mechanical Ventilation on Plasma Concentration Level of R-spondin Proteins
Not yet recruiting NCT02693912 - Changes in Alveolar Macrophage Function During Acute Lung Injury N/A
Completed NCT01659307 - The Effect of Aspirin on REducing iNflammation in Human in Vivo Model of Acute Lung Injury Phase 2
Unknown status NCT01186874 - Epidemiology Research on Acute Lung Injury/Acute Respiratory Distress Syndrome (ALI/ARDS) in Adult ICU in Shanghai N/A
Completed NCT01552070 - Recruitment on Extravascular Lung Water in Acute Respiratory Distress Syndrome (ARDS) Phase 2
Withdrawn NCT00961168 - Work of Breathing and Mechanical Ventilation in Acute Lung Injury N/A
Recruiting NCT00759590 - Comparison of Two Methods to Estimate the Lung Recruitment N/A
Completed NCT00736892 - Incidence of Acute Lung Injury: The Alien Study
Completed NCT02475694 - Acute Lung Injury After Cardiac Surgery: Pathogenesis N/A
Completed NCT00825357 - Biological Markers to Identify Early Sepsis and Acute Lung Injury N/A
Terminated NCT00263146 - Recruitment Maneuvers in ARDS: Effects on Respiratory Function and Inflammatory Markers. N/A
Completed NCT00188058 - Comparison of 2 Strategies of Adjustment of Mechanical Ventilation in Patients With Acute Respiratory Distress Syndrome N/A
Completed NCT00234767 - Study of the Economics of Pulmonary Artery Catheter Use in Patients With Acute Respiratory Distress Syndrome (ARDS) Phase 3
Recruiting NCT02598648 - Role and Molecular Mechanism of Farnesoid X Receptor(FXR) and RIPK3 in the Formation of Acute Respiratory Distress Syndrome in Neonates N/A
Recruiting NCT02948530 - Measurement of Lung Elastance and Transpulmonary Pressure Using Two Different Methods (Lungbarometry)
Completed NCT01532024 - Exploratory Clinical Study of Neutrophil Activation Probe (NAP) for Optical Molecular Imaging in Human Lungs Early Phase 1
Recruiting NCT01992237 - Measuring Energy Expenditure in ECMO (Extracorporeal Membrane Oxygenation) Patients N/A
Completed NCT01486342 - PET Imaging in Patients at Risk for Acute Lung Injury N/A